DOI QR코드

DOI QR Code

Antidepressant-induced Burning Mouth Syndrome - A Unique Case

  • Raghavan, Shubhasini Attavar (Department of Oral Medicine and Radiology, KLE Society's Institute of Dental Sciences) ;
  • Puttaswamiah, Rajiv Nidasale (Vokkaligara Sangha Dental College and Hospital) ;
  • Birur, Praveen N. (Department of Oral Medicine and Radiology, KLE Society's Institute of Dental Sciences) ;
  • Ramaswamy, Bhanushree (Department of Oral Medicine and Radiology, KLE Society's Institute of Dental Sciences) ;
  • Sunny, Sumsum P. (Department of Oral Medicine and Radiology, KLE Society's Institute of Dental Sciences)
  • Received : 2014.01.10
  • Accepted : 2014.03.29
  • Published : 2014.07.01

Abstract

Burning Mouth Syndrome (BMS) is defined as a chronic orofacial pain syndrome, without evidence of mucosal lesions and other clinical signs of disease or laboratory abnormalities. Patients with BMS complain of burning pain in the mouth, xerostomia and taste disturbances. It is more common among women and the median age of occurrence is about 60 years. BMS may be primary or secondary to other diseases. The mainstay in the treatment of BMS includes antidepressants, benzodiazepines, and anticonvulsants. A few cases of BMS caused due to medication have been reported. The causative drugs include angiotensin-converting enzyme inhibitors, anticoagulants, antipsychotics, antiretrovirals, and benzodiazepines. This is a case report of a patient on antidepressants who developed symptoms of BMS thereby causing a dilemma in management.

Keywords

References

  1. Grushka M, Epstein JB, Gorsky M. Burning mouth syndrome. Am Fam Physician 2002; 65: 615-20.
  2. Scala A, Checchi L, Montevecchi M, Marini I, Giamberardino MA. Update on burning mouth syndrome: overview and patient management. Crit Rev Oral Biol Med 2003; 14: 275-91. https://doi.org/10.1177/154411130301400405
  3. Merskey H, Bogduk N; Task Force on Taxonomy of the International Association for the Study of Pain. Lesions of the ear, nose, and oral cavity. In: Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. 2nd ed. Seattle (WA): IASP Press; 1994, pp 74-5.
  4. Grushka M. Clinical features of burning mouth syndrome. Oral Surg Oral Med Oral Pathol 1987; 63: 30-6. https://doi.org/10.1016/0030-4220(87)90336-7
  5. Zakrzewska JM, Hamlyn PJ. Facial pain. In: Epidemiology of pain: a report of the Task Force on Epidemiology of the International Association for the Study of Pain. Edited by Crombie IK, Croft PR, Linton SJ, LeResche L, Von Korff M. Seattle (WA): IASP Press; 1999, pp 175-82.
  6. Lamey PJ. Burning mouth syndrome: approach to successful management. Dent Update 1998; 25: 298-300.
  7. Lamey PJ, Lewis MA. Oral medicine in practice: burning mouth syndrome. Br Dent J 1989; 167: 197-200. https://doi.org/10.1038/sj.bdj.4806969
  8. Cibirka RM, Nelson SK, Lefebvre CA. Burning mouth syndrome: a review of etiologies. J Prosthet Dent 1997; 78: 93-7. https://doi.org/10.1016/S0022-3913(97)70089-1
  9. Klasser GD, Fischer DJ, Epstein JB. Burning mouth syndrome: recognition, understanding, and management. Oral Maxillofac Surg Clin North Am 2008; 20: 255-71, vii. https://doi.org/10.1016/j.coms.2007.12.012
  10. Patton LL, Siegel MA, Benoliel R, De Laat A. Management of burning mouth syndrome: systematic review and management recommendations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 103 Suppl: S39.e1-13. https://doi.org/10.1016/j.tripleo.2005.11.022
  11. Lauria G, Majorana A, Borgna M, Lombardi R, Penza P, Padovani A, et al. Trigeminal small-fiber sensory neuropathy causes burning mouth syndrome. Pain 2005; 115: 332-7. https://doi.org/10.1016/j.pain.2005.03.028
  12. Salort-Llorca C, Minguez-Serra MP, Silvestre FJ. Druginduced burning mouth syndrome: a new etiological diagnosis. Med Oral Patol Oral Cir Bucal 2008; 13: E167-70.
  13. Levenson JL. Burning mouth syndrome as a side effect of SSRIs. J Clin Psychiatry 2003; 64: 336-7.
  14. Okeson JP. The various presentations of pain. In: Bell's orofacial pains: the clinical management of orofacial pain. 6th ed. Chicago (CA): Quintessence; 2005, pp 107-28.
  15. Rang HP, Dale MM, Ritter JM, Flower RJ, Henderson G. Antidepressant drugs. In: Rang and Dale's pharmacology. 7th ed. Edinburgh: Elsevier/Churchill Livingstone; 2012, pp 564-83.

Cited by

  1. Fluoxetine vol.1512, pp.1, 2014, https://doi.org/10.1007/s40278-014-2314-3
  2. Is there an association between drugs and burning mouth syndrome? A case–control study vol.25, pp.6, 2014, https://doi.org/10.1111/odi.13116
  3. Burning Mouth Syndrome and Contact Dermatitis vol.31, pp.4, 2020, https://doi.org/10.1097/der.0000000000000565